Detalhe da pesquisa
1.
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.
Cell
; 185(11): 1860-1874.e12, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568033
2.
Dectin-1-Independent Macrophage Phagocytosis of Mycobacterium abscessus.
Int J Mol Sci
; 24(13)2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37446240
3.
A Flow Cytometric Method for Isolating Cystic Fibrosis Airway Macrophages from Expectorated Sputum.
Am J Respir Cell Mol Biol
; 61(1): 42-50, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742539
4.
In Vivo Proteome of Pseudomonas aeruginosa in Airways of Cystic Fibrosis Patients.
J Proteome Res
; 18(6): 2601-2612, 2019 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31060355
5.
Cystic Fibrosis Airways: Does Disease Stem from Faulty Stem Cells?
Am J Respir Crit Care Med
; 208(9): 913-914, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751560
6.
Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.
Am J Respir Crit Care Med
; 195(12): 1617-1628, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222269
7.
Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive Infection In Vivo.
Infect Immun
; 85(1)2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795361
8.
Rats Race to Keep Pace in the Growing Cystic Fibrosis Model Space.
Am J Respir Crit Care Med
; 202(9): 1212-1214, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692578
9.
MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection.
Front Cell Infect Microbiol
; 14: 1275940, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352056
10.
MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection.
bioRxiv
; 2023 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712028
11.
Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway.
Tuberculosis (Edinb)
; 138: 102276, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36417800
12.
Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy.
Lancet Respir Med
; 11(10): 916-931, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699420
13.
The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation.
Clin Chest Med
; 43(4): 647-665, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344072
14.
Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis.
Ann Am Thorac Soc
; 19(11): 1818-1826, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713619
15.
Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis.
Am J Respir Cell Mol Biol
; 54(4): 594-7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27035067
16.
Spontaneous phthiocerol dimycocerosate-deficient variants of Mycobacterium tuberculosis are susceptible to gamma interferon-mediated immunity.
Infect Immun
; 79(7): 2829-38, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576344
17.
Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies.
Cell Rep
; 34(8): 108782, 2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626358
18.
CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis.
Front Pharmacol
; 11: 1219, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33013356
19.
Strong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function.
J Cyst Fibros
; 19(4): 608-613, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813753
20.
Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis.
ERJ Open Res
; 6(2)2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32337217